Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Microvast
MVST
$369M
| $2.44M | ﹤0.01% |
1,741,880
+280,818
| +19% | +$377K |
|
2552
Liberty Latin America Class A
LILA
$1.68B
| $2.44M | ﹤0.01% |
490,456
-29,270
| -6% | -$141K |
|
|
SHCR
2553
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $2.43M | ﹤0.01% |
2,246,383
+14,429
| +0.6% | +$14.8K |
|
2554
BP
BP
$110B
| $2.42M | ﹤0.01% |
68,238
+8,735
| +15% | +$320K |
|
2555
Westrock Coffee
WEST
$809M
| $2.41M | ﹤0.01% |
236,524
+10,604
| +5% | +$94.9K |
|
2556
Qiagen
QGEN
$8.94B
| $2.41M | ﹤0.01% |
52,287
+14,743
| +39% | +$627K |
|
2557
Phathom Pharmaceuticals
PHAT
$758M
| $2.4M | ﹤0.01% |
262,524
+15,843
| +6% | +$137K |
|
2558
AngioDynamics
ANGO
$658M
| $2.38M | ﹤0.01% |
304,145
-2,468
| -0.8% | -$17.1K |
|
2559
Qfin Holdings
QFIN
$1.53B
| $2.38M | ﹤0.01% |
150,641
-2,684
| -2% | -$41.1K |
|
|
FSR
2560
DELISTED
Fisker Inc.
FSR
| $2.36M | ﹤0.01% |
1,351,016
-123,643
| -8% | -$437K |
|
2561
IMAX
IMAX
$2.84B
| $2.36M | ﹤0.01% |
157,380
-392
| -0.2% | -$6.71K |
|
2562
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
| $2.36M | ﹤0.01% |
45,420
-3,275
| -7% | -$159K |
|
2563
GSK
GSK
$101B
| $2.35M | ﹤0.01% |
63,511
+18,807
| +42% | +$675K |
|
2564
GeoPark
GPRK
$592M
| $2.35M | ﹤0.01% |
274,538
+81,984
| +43% | +$775K |
|
2565
Allogene Therapeutics
ALLO
$721M
| $2.35M | ﹤0.01% |
732,835
-48,493
| -6% | -$138K |
|
2566
CarParts.com
PRTS
$48.7M
| $2.33M | ﹤0.01% |
73,584
+1,405
| +2% | +$47.5K |
|
2567
Aspen Aerogels
ASPN
$507M
| $2.32M | ﹤0.01% |
146,742
-2,416
| -2% | -$24.9K |
|
2568
Rush Street Interactive
RSI
$2.85B
| $2.31M | ﹤0.01% |
514,936
+30,101
| +6% | +$125K |
|
2569
Blend Labs
BLND
$338M
| $2.31M | ﹤0.01% |
904,339
+16,561
| +2% | +$25K |
|
|
AGTI
2570
DELISTED
Agiliti Inc
AGTI
| $2.3M | ﹤0.01% |
290,718
+24,822
| +9% | +$168K |
|
|
HTB
2571
HomeTrust Bancshares
HTB
$832M
| $2.29M | ﹤0.01% |
85,019
+6,611
| +8% | +$151K |
|
2572
Entrada Therapeutics
TRDA
$300M
| $2.28M | ﹤0.01% |
151,358
-3,866
| -2% | -$57.3K |
|
2573
MINISO
MNSO
$3.55B
| $2.27M | ﹤0.01% |
111,369
-2,013
| -2% | -$48.3K |
|
|
ONTF
2574
DELISTED
ON24
ONTF
| $2.27M | ﹤0.01% |
287,811
-5,767
| -2% | -$40K |
|
2575
Axogen
AXGN
$2.63B
| $2.26M | ﹤0.01% |
331,313
+21,237
| +7% | +$118K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.